Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
23.01
-2.07 (-8.25%)
At close: Jan 27, 2026

SHE:301408 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2018 - 2019
9,2044,4126,380---
Upgrade
Market Cap Growth
98.70%-30.85%----
Upgrade
Enterprise Value
9,8154,5796,088---
Upgrade
Last Close Price
23.0110.9415.67---
Upgrade
PE Ratio
49.9732.0455.64---
Upgrade
PS Ratio
1.790.971.68---
Upgrade
PB Ratio
4.262.143.23---
Upgrade
P/TBV Ratio
13.604.655.02---
Upgrade
P/FCF Ratio
14.4310.81----
Upgrade
P/OCF Ratio
11.997.7248.57---
Upgrade
EV/Sales Ratio
1.901.011.60---
Upgrade
EV/EBITDA Ratio
16.1517.4735.41---
Upgrade
EV/EBIT Ratio
32.3220.5140.46---
Upgrade
EV/FCF Ratio
15.3911.21----
Upgrade
Debt / Equity Ratio
0.650.600.650.810.760.16
Upgrade
Debt / EBITDA Ratio
2.322.383.581.942.230.85
Upgrade
Debt / FCF Ratio
2.213.00-11.035.59-
Upgrade
Asset Turnover
1.000.961.061.441.441.64
Upgrade
Inventory Turnover
3.693.754.014.504.134.63
Upgrade
Quick Ratio
0.590.700.970.730.690.84
Upgrade
Current Ratio
1.091.191.441.251.261.62
Upgrade
Return on Equity (ROE)
9.93%7.54%8.05%18.50%9.30%14.14%
Upgrade
Return on Assets (ROA)
3.67%2.96%2.62%6.26%4.11%6.47%
Upgrade
Return on Invested Capital (ROIC)
8.43%7.90%7.44%14.62%9.37%15.76%
Upgrade
Return on Capital Employed (ROCE)
10.60%8.40%5.70%18.70%9.80%17.00%
Upgrade
Earnings Yield
2.03%3.12%1.80%---
Upgrade
FCF Yield
6.93%9.25%-1.41%---
Upgrade
Dividend Yield
0.40%0.91%0.64%---
Upgrade
Payout Ratio
30.42%40.66%12.81%2.57%6.23%7.77%
Upgrade
Buyback Yield / Dilution
0.10%-2.43%-15.59%-3.02%2.92%-5.34%
Upgrade
Total Shareholder Return
0.52%-1.51%-14.95%-3.02%2.92%-5.34%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.